EF
WST icon

Empowered Funds’s West Pharmaceutical WST Stock Holding History

Empowered Funds’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9.75M Buy
27,152
+24,435
+899% +$7.47M 0.05% 426
2026
Q1 		$681K Buy
+2,717
New +$676K ﹤0.01% 1543
2025
Q4 		– Sell
-1,863
Closed -$489K – 1937
2025
Q3 		$489K Buy
1,863
+84
+5% +$20.4K ﹤0.01% 1414
2025
Q2 		$389K Buy
1,779
+168
+10% +$35.9K ﹤0.01% 1406
2025
Q1 		$361K Buy
1,611
+224
+16% +$61.7K 0.01% 1344
2024
Q4 		$454K Buy
1,387
+10
+0.7% +$3.15K 0.01% 1216
2024
Q3 		$413K Buy
1,377
+52
+4% +$15.9K 0.01% 1153
2024
Q2 		$436K Sell
1,325
-260
-16% -$91.9K 0.01% 1093
2024
Q1 		$627K Buy
1,585
+642
+68% +$237K 0.01% 1020
2023
Q4 		$332K Buy
943
+195
+26% +$69K 0.01% 1087
2023
Q3 		$281K Buy
748
+179
+31% +$69.2K 0.01% 1076
2023
Q2 		$218K Buy
+569
New +$203K 0.01% 1055
2021
Q2 		– Sell
-6,282
Closed -$1.78M – 311
2021
Q1 		$1.78M Hold
6,282
– – 0.34% 107
2020
Q4 		$1.78M Buy
+6,282
New +$1.76M 0.34% 107
2020
Q3 		– Sell
-6,120
Closed -$1.39M – 159
2020
Q2 		$1.39M Buy
+6,120
New +$1.2M 0.54% 66

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Empowered Funds's WST Position: Q2 2026 in Review

Empowered Funds increased its West Pharmaceutical (WST) stake by 899% in Q2 2026, buying an estimated $7.47M and bringing the position to 27,152 shares worth $9.75M. The position accounts for 0.05% of the portfolio, ranked #426.

Empowered Funds first reported a position in WST in Q2 2020 and has held it in 15 quarters since. 830 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Empowered Funds held 27,152 shares of West Pharmaceutical worth $9.75M as of Q2 2026.
  • Empowered Funds bought 24,435 West Pharmaceutical shares in Q2 2026, an estimated $7.47M.
  • West Pharmaceutical made up 0.05% of Empowered Funds's portfolio in Q2 2026, its #426 holding.
  • Empowered Funds first reported a position in West Pharmaceutical in Q2 2020 and has held it in 15 quarters since.
  • 830 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Empowered Funds's 13F filing for Q2 2026, filed 17 Aug 2026.